Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics -> Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Checklist Plug-and-play starting point Manufacturing Automation

Checklist: LIMS Upgrade and Patch Impact Assessment

A runnable checklist for assessing and re-verifying a LIMS after a vendor-pushed upgrade or patch: release-note review, sandbox testing, re-running high-risk OQ scripts, static-data integrity, and a rollback plan, with pass/fail/NA columns and a filled specimen.

Document type: Checklist

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use checklist for assessing the impact of a LIMS version upgrade or vendor-pushed patch and re-verifying the validated state afterward.

It applies whether the lab initiates the upgrade or a SaaS vendor pushes it on its own release schedule. Replace every <<FILL: ...>> placeholder and route it through your normal change control. This is general guidance to adapt and verify, not legal or regulatory advice.

Document control header

FieldEntry
Document titleLIMS Upgrade and Patch Impact Assessment
Document number<<FILL: CL-ID>>
System<<FILL: LIMS name and version, from-version to to-version>>
Change control reference<<FILL>>
Version<<FILL: version, e.g. 1.0>>
Effective date<<FILL>>
Document owner<<FILL: role, e.g. Validation Lead>>

When to use this checklist

Run it for every LIMS version upgrade, major patch, or platform migration, before the change is applied in production, and again after, to confirm the validated state held. For a SaaS platform where the vendor controls upgrade timing, run the pre-change items as soon as the release notice arrives, even if the notice period is short.

Section A: before the upgrade

#ItemPass / Fail / NAEvidence / note
A1Vendor release notes obtained and reviewed for changes to calculation engines, rounding behavior, spec-evaluation logic, audit trail structure, or e-signature handling
A2Sandbox or staging environment available that mirrors the current production configuration
A3List of high-risk functions from the original OQ identified for re-test (spec evaluation, calculations, audit trail, e-signatures, access control, interfaces)
A4Critical static data (specs, methods, units) inventory confirmed and a pre-upgrade snapshot taken for comparison
A5Rollback or interim-control plan documented in case testing surfaces a problem after the upgrade is live

Section B: testing in the sandbox/staging environment

#ItemPass / Fail / NAEvidence / note
B1High-risk OQ scripts re-executed in the upgraded staging environment, including boundary and rounding test cases
B2Interface test cases re-executed (instrument/CDS to LIMS), including a batch transfer, not a single-sample test
B3Critical static data compared before and after the upgrade; zero unexplained changes
B4Any deviation from expected behavior logged, root-caused, and dispositioned before production deployment

Section C: after production deployment

#ItemPass / Fail / NAEvidence / note
C1Production configuration spot-checked against the pre-upgrade snapshot for the same critical static data
C2A sample of live, in-process results reviewed post-upgrade for the affected functions (spec evaluation, calculations) to confirm no unexpected behavior in real use
C3Change control record completed, referencing the release notes, the test evidence, and the disposition, even when no functional changes were found
C4Users notified of any behavior change that affects their workflow (for example, a changed rounding display)

Acceptance criteria

  • Every high-risk function from the original OQ is re-tested in staging before the upgrade reaches production, with no exceptions for “minor” patches.
  • Every deviation found in testing is resolved and re-tested, or formally risk-accepted with documented rationale, before production deployment.
  • Critical static data is confirmed unchanged, or any change is explained and re-verified against source.
  • The change control record exists and is closed even when the upgrade required no corrective action; “we upgraded and nothing broke” is documented, not assumed.

Signoff

RoleNameSignatureDate
Validation lead<<FILL>>
QA<<FILL>>
System owner / lab<<FILL>>

References

GAMP 5, Second Edition (ISPE, 2022), change and configuration management across the system lifecycle. EudraLex Volume 4, Annex 11, clause on configuration and change management. 21 CFR 211.68, controls over automated equipment and systems.

Confirm the current version of each reference before issue.


Filled specimen

An excerpt from a completed assessment of a vendor-pushed patch to a cloud LIMS. Illustrative only.

#ItemResultEvidence / note
A1Release notes reviewedPassVendor release notes cited “improved decimal handling in calculated fields”; flagged as high-risk for rounding behavior despite the cosmetic wording
B1High-risk OQ scripts re-executedFail, then PassBoundary test at 0.20% NMT limit returned an unexpected rounding result in staging; root cause: the patch changed the default rounding mode for one calculation type; corrected via configuration before production deployment and re-tested, Pass
C3Change control recordPassCC-2026-0341 closed, referencing the release notes, the staging deviation, the corrective configuration, and the re-test evidence

This is the exact failure mode the checklist exists to catch: a release note that reads as a minor performance improvement actually changed rounding behavior, and the boundary test case, not a general smoke test, is what caught it before it reached production.

Common inspection findings this checklist prevents

  • A vendor patch applied directly to production with no sandbox testing, on the assumption that a routine patch could not affect validated behavior.
  • Release notes never reviewed in detail, so a calculation or rounding change goes unnoticed until a near-limit result is reported incorrectly weeks later.
  • “The vendor tested it” accepted as sufficient evidence with no site-specific re-verification of the lab’s own configuration and specs.
  • No change control record for an upgrade that produced no findings, leaving no evidence the impact was ever actually assessed.

How to adapt this checklist

  1. Scale the high-risk function list in Section A3 to your own risk assessment and original OQ scope.
  2. For a self-hosted LIMS where you control upgrade timing, build in a longer pre-production soak period in Section B.
  3. For a SaaS platform with vendor-controlled timing, keep a standing rollback or interim-control plan ready rather than drafting one after each notice arrives.
  4. Retain completed checklists with the change control record as the evidence that the validated state was maintained.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.